Is the Imaging Radiation Oncology Core Head and Neck Credentialing Phantom an Effective Surrogate for Different Anatomic Sites?

Fre'Etta M D Brooks, Mallory C Glenn, Victor Hernandez, Jordi Saez, Julianne M Pollard-Larkin, Christine B Peterson, Rebecca M Howell, Christopher L Nelson, Catharine H Clark, Stephen F Kry
{"title":"Is the Imaging Radiation Oncology Core Head and Neck Credentialing Phantom an Effective Surrogate for Different Anatomic Sites?","authors":"Fre'Etta M D Brooks, Mallory C Glenn, Victor Hernandez, Jordi Saez, Julianne M Pollard-Larkin, Christine B Peterson, Rebecca M Howell, Christopher L Nelson, Catharine H Clark, Stephen F Kry","doi":"10.1016/j.ijrobp.2024.09.053","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>The Imaging Radiation Oncology Core (IROC) head and neck (H&N) phantom is used to credential institutions for intensity modulated radiation therapy delivery for all anatomic sites where delivery of modulated therapy is a primary challenge. This study evaluated how appropriate the use of this phantom is for varied clinical anatomy by evaluating how closely the IROC H&N phantom described clinical dose errors from beam modeling compared with various anatomic sites.</p><p><strong>Methods and materials: </strong>The multileaf collimator (MLC) offset, transmission, percent depth dose, and 7 additional beam modeling parameters for a Varian accelerator were modified in RayStation to match community data at the 2.5th, 25th, 50th, 75th, and 97.5th percentile levels. Modifications were evaluated on 25 H&N phantom cases and 25 clinical cases (H&N, prostate, lung, mesothelioma, and brain), generating 2000 plan perturbations. Differences in mean dose delivered to clinical target volumes and maximum dose to organs at risk were compared between phantom and clinical plans to assess the relationship between dose deviations in phantom versus clinical target volumes and as a function of 18 different complexity metrics.</p><p><strong>Results: </strong>Perturbations to MLC offset and transmission parameters demonstrated the greatest impact on dose accuracy for phantom and clinical plans (for all anatomic sites). The phantom demonstrated equivalent or greater sensitivity to these parameter perturbations compared with clinical sites, largely aligning with treatment complexity. The mean MLC gap best described the impact of errors in treatment planning system beam modeling parameters in phantom plans and clinical plans from various anatomic sites.</p><p><strong>Conclusions: </strong>When compared across various anatomic sites, the IROC H&N credentialing phantom exhibited similar or greater sensitivity to errors in the treatment planning system. As such, it is a suitable surrogate device for assessing institutional performance across various anatomic sites. If an institution successfully irradiates the phantom, that result confers confidence that intensity modulated radiation therapy to a wide range of anatomic sites can be successfully delivered by the institution.</p>","PeriodicalId":14215,"journal":{"name":"International Journal of Radiation Oncology Biology Physics","volume":" ","pages":""},"PeriodicalIF":6.4000,"publicationDate":"2024-10-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Radiation Oncology Biology Physics","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.ijrobp.2024.09.053","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Purpose: The Imaging Radiation Oncology Core (IROC) head and neck (H&N) phantom is used to credential institutions for intensity modulated radiation therapy delivery for all anatomic sites where delivery of modulated therapy is a primary challenge. This study evaluated how appropriate the use of this phantom is for varied clinical anatomy by evaluating how closely the IROC H&N phantom described clinical dose errors from beam modeling compared with various anatomic sites.

Methods and materials: The multileaf collimator (MLC) offset, transmission, percent depth dose, and 7 additional beam modeling parameters for a Varian accelerator were modified in RayStation to match community data at the 2.5th, 25th, 50th, 75th, and 97.5th percentile levels. Modifications were evaluated on 25 H&N phantom cases and 25 clinical cases (H&N, prostate, lung, mesothelioma, and brain), generating 2000 plan perturbations. Differences in mean dose delivered to clinical target volumes and maximum dose to organs at risk were compared between phantom and clinical plans to assess the relationship between dose deviations in phantom versus clinical target volumes and as a function of 18 different complexity metrics.

Results: Perturbations to MLC offset and transmission parameters demonstrated the greatest impact on dose accuracy for phantom and clinical plans (for all anatomic sites). The phantom demonstrated equivalent or greater sensitivity to these parameter perturbations compared with clinical sites, largely aligning with treatment complexity. The mean MLC gap best described the impact of errors in treatment planning system beam modeling parameters in phantom plans and clinical plans from various anatomic sites.

Conclusions: When compared across various anatomic sites, the IROC H&N credentialing phantom exhibited similar or greater sensitivity to errors in the treatment planning system. As such, it is a suitable surrogate device for assessing institutional performance across various anatomic sites. If an institution successfully irradiates the phantom, that result confers confidence that intensity modulated radiation therapy to a wide range of anatomic sites can be successfully delivered by the institution.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
IROC H&N 凭证模型是不同解剖部位的有效替代物吗?将 IROC 的 H&N 模型用于不同部位。
目的:IROC 头颈部模型被用于对所有解剖部位进行 IMRT 治疗的机构进行认证,在这些部位进行调制治疗是一项主要挑战。本研究通过评估 IROC 头颈部模型与不同解剖部位相比,在多大程度上描述了射束建模产生的临床剂量误差,从而评估了该模型在不同临床解剖部位的适用性:在 RayStation 中修改了瓦里安加速器的 MLC 偏移、透射、PDD 和其他七个射束建模参数,以匹配 2.5、25、50、75 和 97.5 百分位数水平的社区数据。对 25 个 H&N 模型病例和 25 个临床病例(H&N、前列腺、肺、间皮瘤和脑)的修改进行了评估,产生了 2,000 次计划扰动。比较了模型和临床计划的临床靶体积(CTV)和危险器官(OAR)的平均剂量差异,以评估模型和临床 CTV 的剂量偏差之间的关系,并将其作为 18 种不同复杂性指标的函数:结果:对 MLC 偏移和传输参数的干扰对模型和临床计划(所有解剖部位)的剂量准确性影响最大。与临床部位相比,模型对这些参数扰动的敏感度相当或更高,这在很大程度上与治疗复杂性相一致。平均 MLC 差距最能说明不同解剖部位的模型计划和临床计划中 TPS 光束建模参数误差的影响:在对不同解剖部位进行比较时,IROC H&N 证书模型对治疗计划系统误差的敏感性相似或更高。因此,它是评估不同解剖部位机构绩效的合适替代设备。如果一家机构成功地对该模型进行了照射,那么这一结果就会让人相信,该机构可以成功地对各种解剖部位进行 IMRT 治疗。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
11.00
自引率
7.10%
发文量
2538
审稿时长
6.6 weeks
期刊介绍: International Journal of Radiation Oncology • Biology • Physics (IJROBP), known in the field as the Red Journal, publishes original laboratory and clinical investigations related to radiation oncology, radiation biology, medical physics, and both education and health policy as it relates to the field. This journal has a particular interest in original contributions of the following types: prospective clinical trials, outcomes research, and large database interrogation. In addition, it seeks reports of high-impact innovations in single or combined modality treatment, tumor sensitization, normal tissue protection (including both precision avoidance and pharmacologic means), brachytherapy, particle irradiation, and cancer imaging. Technical advances related to dosimetry and conformal radiation treatment planning are of interest, as are basic science studies investigating tumor physiology and the molecular biology underlying cancer and normal tissue radiation response.
期刊最新文献
Spine SBRT in Geriatric Patients: Implications of Age and Dose on Iatrogenic Vertebral Compression Fracture Risk. The association of linear energy transfer and dose with radiation necrosis after pencil beam scanning proton therapy in pediatric posterior fossa tumors: Association of dose and LET with radiation necrosis. Data-Driven Volumetric CT Image Generation from Surface Structures using a Patient-Specific Deep Leaning Model. Phase II trial of consolidative stereotactic body radiation therapy in patients with metastatic oncogene-driven non-small cell lung carcinoma treated with tyrosine kinase inhibitors. Docetaxel/cisplatin chemotherapy followed by pelvic radiation therapy in patients with high-risk endometrial cancer after staging surgery: a phase II study.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1